Harrow (HROW) Enterprise Value (2010 - 2026)
Harrow's (HROW) quarterly Enterprise Value came in at -$95.0 million in Q1 2026, down 41.62% year-on-year from -$162.7 million in Q1 2025, and down 29.63% quarter-over-quarter from -$73.3 million in Q4 2025.
Harrow (HROW) Enterprise Value (2010 - 2026) Analysis & Trends
Harrow's Enterprise Value history runs 17 years deep, the most recent figure standing at -$95.0 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 41.62% year-over-year to -$95.0 million in Q1 2026; TTM through Mar 2026 was -$95.0 million, a 41.62% decrease from a year earlier, with the FY2025 full-year figure at -$73.3 million, down 53.95% from the prior year.
- Enterprise Value slipped to -$95.0 million in Q1 2026 per HROW's latest filing, from -$73.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$27.2 million in Q1 2023 and bottomed at -$102.2 million in Q4 2022.
- The 5-year median for Enterprise Value is -$71.3 million (2024), against an average of -$64.8 million.
- Across the five-year window, Enterprise Value tumbled 642.75% in 2022 and soared 46.54% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$102.2 million in 2022, then gained by 18.68% to -$83.1 million in 2023, then jumped by 42.73% to -$47.6 million in 2024, then tumbled by 53.95% to -$73.3 million in 2025, then slipped by 29.63% to -$95.0 million in 2026.
- Per Business Quant, the three latest HROW Enterprise Value figures stand at -$95.0 million (Q1 2026), -$73.3 million (Q4 2025), and -$74.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | -95.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.00 Mn |
| Dec 31, 2025 | -73.28 Mn |
| Sep 30, 2025 | -74.65 Mn |
| Jun 30, 2025 | -53.32 Mn |
| Mar 31, 2025 | -67.08 Mn |
| Dec 31, 2024 | -47.60 Mn |
| Sep 30, 2024 | -72.96 Mn |
| Jun 30, 2024 | -71.32 Mn |
| Mar 31, 2024 | -76.33 Mn |
| Dec 31, 2023 | -83.12 Mn |
| Sep 30, 2023 | -74.23 Mn |
| Jun 30, 2023 | -30.03 Mn |
| Mar 31, 2023 | -27.23 Mn |
| Dec 31, 2022 | -102.21 Mn |
| Sep 30, 2022 | -49.48 Mn |
| Jun 30, 2022 | -51.99 Mn |
| Mar 31, 2022 | -50.95 Mn |
| Dec 31, 2021 | -51.03 Mn |
| Sep 30, 2021 | -68.20 Mn |
| Jun 30, 2021 | -85.42 Mn |